Biotech Boom Sends One ETF Flying to Close the Year

Dec.04 -- The ETF industry has something for everyone -- the ALPS Medical Breakthrough ETF (ticker: SBIO) tracks biotech and pharmaceutical names with one or more drugs in Phase two or three of FDA clinical trials. Eight of November’s top 10 performing ETFs focused on biotec, or a related theme. In this week's "There's an ETF for That", Bloomberg's Scarlet Fu puts ’SBIO’ under the microscope.